← Contracts
PT
2026/0126 - Convite à apresentação de proposta por ajuste direto para aquisição de AMIVANTAMAB [50 MG/ML; 7 ML; SOL INJ; FRS], BOSENTANO [32 MG; COMP DISP], BEDAQUILINA [100 MG; CÁP/COMP], DARUNAVIR [100 MG/ML; SUSP ORAL; FRS], TECLISTAMAB [90 MG/ML; 1,7 ML; SOL INJ; FRS] e TECLISTAMAB [10 MG/ML; 3 ML; SOL INJ; FRS]
ID 12825893
· Portal BASE
Price
Base Price
€1,602,358
.00
Effective Price
€75,912
.00
-95.3%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
JANSSEN - CILAG FARMACÊUTICA LDA
NIF 500189412
Dates
- Publication
- 23 Jan 2026
- Celebration
- 22 Jan 2026
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 1602358.0
- Total effective price
- 75912.0
- Ratio
- 0.0474
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.0474 outside [0.5, 1.5]
Detected 2026-03-06